Riken Vitamin Co.,ltd. Forecast, price target & analysts
Why the stock moved Beta
Riken Vitamin Co.,ltd. Target price 2026 - Analyst rating & recommendation
There are currently no analyst estimates including target prices 2026, ratings or recommendations for the Riken Vitamin Co.,ltd. stock.
Sales and Margin forecast 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 96.30 | 99.18 |
| 0.75% | 2.99% | |
| EBITDA Margin | 7.53% | 12.42% |
| 20.11% | 64.84% | |
| Net Margin | 7.31% | 8.96% |
| 25.62% | 22.65% |
2 Analysts have issued a sales forecast Riken Vitamin Co.,ltd. 2027 . The average Riken Vitamin Co.,ltd. sales estimate is
This results in the following potential growth metrics:
2 Riken Vitamin Co.,ltd. Analysts have issued a net profit forecast 2027. The average Riken Vitamin Co.,ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 238.17 | 306.14 |
| 23.19% | 28.54% | |
| P/E | 10.84 | |
| EV/Sales | 0.66 |
2 Analysts have issued a Riken Vitamin Co.,ltd. forecast for earnings per share. The average Riken Vitamin Co.,ltd. EPS is
This results in the following potential growth metrics and future valuations:
Riken Vitamin Co.,ltd....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
